USFDA completes inspection of Dahej unit: Ajanta Pharma

"Company's formulation facility at Dahej was inspected by United States Food and Drug Administration (USFDA) from April 3 to 7, 2017," Ajanta Pharma said in a filing to BSE.

April 10, 2017 / 13:42 IST

Myth 3: Everyone who has a mental illness needs medication to manage symptoms | Bulthuis says no two patients are the same. While medicines can help manage symptoms, there are some people with mental illness who do not require medication. For others, medicine is essential for recovery. (Representative image)

26 Aug, 2025 12:21

Volume

Todays L/H

Drug firm Ajanta Pharma today said the US health regulator has successfully completed inspection of its Dahej facility.

"Company's formulation facility at Dahej was inspected by United States Food and Drug Administration (USFDA) from April 3 to 7, 2017," Ajanta Pharma said in a filing to BSE.

At the end of the inspection, no Form 483 was issued to the company, it added.

Form 483 is issued to a company's management after completion of inspection of its facility to notify regarding objectionable conditions.

Shares of Ajanta Pharma were trading 1.24 per cent up at at Rs 1,741 apiece on BSE.

first published: Apr 10, 2017 01:28 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.